Aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical Drug Interactions
A total of 1218 drugs are known to interact with aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical.
- 73 major drug interactions
- 1102 moderate drug interactions
- 43 minor drug interactions
Check for interactions with aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical
Common medications checked in combination with aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Dilaudid (hydromorphone)
- Dulcolax Stool Softener (docusate)
- Epivir (lamivudine)
- Flexeril (cyclobenzaprine)
- Kaletra (lopinavir / ritonavir)
- Lidocaine Viscous (lidocaine topical)
- Neupogen (filgrastim)
- Nexium (esomeprazole)
- Viread (tenofovir)
- Vitamin B Complex 100 (multivitamin)
- Zinc 50 mg Pink (zinc sulfate)
Aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical alcohol/food interactions
There are 2 alcohol/food interactions with aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical
Aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical disease interactions
There are 16 disease interactions with aluminum hydroxide / diphenhydramine / lidocaine / magnesium hydroxide / simethicone topical which include:
- anticholinergic effects
- asthma/COPD
- depression
- inflammatory bowel disease
- intestinal obstruction disorders
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- renal dysfunction
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- resp depression
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
